Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05630625 · ClinicalTrials.gov registry record · NA

The Drinking Dashboard Study

A NA study of Alcohol Drinking, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
169
Enrollment target
1
Study location

NCT05630625: Completed NA study of Alcohol Drinking, sponsored by University of Missouri-Columbia.

NCT05630625 is a NA study of Alcohol Drinking that has completed, run by University of Missouri-Columbia. The registered enrollment target is 169 participants, below the 628-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05630625, a NA study of Alcohol Drinking, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
169 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop and pilot test the efficacy of a "Drinking Dashboard" providing participants weekly feedback on the risk factors and consequences of blackout.

Primary Outcome

% of eligible screening participants who (yes/no) complete the baseline assessment (no specific tool)

Conditions Studied

Interventions

  • BEHAVIORAL Drinking Dashboard

Study Locations (1)

Missouri

  • University of Missouri-Columbia - Columbia

Trial Details

FieldValue
Enrollment Target 169 participants
Start Date 2023-05-30
Est. Completion 2024-04-09
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT05630625 record still lists

NCT05630625 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 628-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Drinking Dashboard is the first listed.

NCT05630625 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05630625 about?

NCT05630625 is a clinical study titled "The Drinking Dashboard Study". This study aims to develop and pilot test the efficacy of a "Drinking Dashboard" providing participants weekly feedback on the risk factors and consequences of blackout.

What is the current status of trial NCT05630625?

This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2023-05-30. Estimated completion is 2024-04-09.

What conditions does trial NCT05630625 study?

This clinical trial studies the following conditions: Alcohol Drinking.

What interventions are being tested in trial NCT05630625?

The interventions under investigation include: Drinking Dashboard (BEHAVIORAL).

Who is sponsoring clinical trial NCT05630625?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05630625 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05630625's enrollment target sits among peer trials

169 46th of 85 higher than 40 of 85 other Alcohol Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06191484 · 169 participants · NA

    Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05630625, the US trial registry maintained by the National Library of Medicine. NCT05630625 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.